SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-024597
Filing Date
2021-05-05
Accepted
2021-05-05 06:01:56
Documents
2
Period of Report
2021-05-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea140337-6k_tiziana.htm 6-K 14781
2 REGULATORY NEWS SERVICE ANNOUNCEMENT, DATED MAY 5, 2021 ea140337ex99-1_tiziana.htm EX-99.1 16851
  Complete submission text file 0001213900-21-024597.txt   32664
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 21890997
SIC: 2834 Pharmaceutical Preparations